Report Detail

Pharma & Healthcare Global Granisetron Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3646059
  • |
  • 06 August, 2019
  • |
  • Global
  • |
  • 139 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.

Scope of the Report:
The global Granisetron market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Granisetron.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Granisetron market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Granisetron market by product type and applications/end industries.

Market Segment by Companies, this report covers
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Transdermal system
Injection
Oral

Market Segment by Applications, can be divided into
Chemotherapy
Post operative


Table of Contents

    1 Granisetron Market Overview

    • 1.1 Product Overview and Scope of Granisetron
    • 1.2 Classification of Granisetron by Types
      • 1.2.1 Global Granisetron Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Granisetron Revenue Market Share by Types in 2018
      • 1.2.3 Transdermal system
      • 1.2.4 Injection
      • 1.2.5 Oral
    • 1.3 Global Granisetron Market by Application
      • 1.3.1 Global Granisetron Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Chemotherapy
      • 1.3.3 Post operative
    • 1.4 Global Granisetron Market by Regions
      • 1.4.1 Global Granisetron Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Granisetron Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Granisetron Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Granisetron Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Granisetron Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Granisetron Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Granisetron (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Kyowa Kirin
      • 2.1.1 Business Overview
      • 2.1.2 Granisetron Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Kyowa Kirin Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Heron Therapeutics
      • 2.2.1 Business Overview
      • 2.2.2 Granisetron Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Heron Therapeutics Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Fresenius Kabi
      • 2.3.1 Business Overview
      • 2.3.2 Granisetron Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Fresenius Kabi Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Hikma Pharmaceuticals
      • 2.4.1 Business Overview
      • 2.4.2 Granisetron Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Hikma Pharmaceuticals Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Granisetron Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Cipla
      • 2.6.1 Business Overview
      • 2.6.2 Granisetron Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Cipla Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Sandoz
      • 2.7.1 Business Overview
      • 2.7.2 Granisetron Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Sandoz Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Wockhardt
      • 2.8.1 Business Overview
      • 2.8.2 Granisetron Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Wockhardt Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Mylan
      • 2.9.1 Business Overview
      • 2.9.2 Granisetron Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Mylan Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 APOTEX
      • 2.10.1 Business Overview
      • 2.10.2 Granisetron Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 APOTEX Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Dr.Reddy's
      • 2.11.1 Business Overview
      • 2.11.2 Granisetron Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Dr.Reddy's Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Bluepharma
      • 2.12.1 Business Overview
      • 2.12.2 Granisetron Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Bluepharma Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Natco Pharma
      • 2.13.1 Business Overview
      • 2.13.2 Granisetron Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Natco Pharma Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Akorn
      • 2.14.1 Business Overview
      • 2.14.2 Granisetron Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Akorn Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Taro Pharmaceutical
      • 2.15.1 Business Overview
      • 2.15.2 Granisetron Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Taro Pharmaceutical Granisetron Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Aurobindo
      • 2.16.1 Business Overview
      • 2.16.2 Granisetron Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Aurobindo Granisetron Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Granisetron Market Competition, by Players

    • 3.1 Global Granisetron Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Granisetron Players Market Share
      • 3.2.2 Top 10 Granisetron Players Market Share
    • 3.3 Market Competition Trend

    4 Global Granisetron Market Size by Regions

    • 4.1 Global Granisetron Revenue and Market Share by Regions
    • 4.2 North America Granisetron Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Granisetron Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Granisetron Revenue and Growth Rate (2014-2019)
    • 4.5 South America Granisetron Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Granisetron Revenue and Growth Rate (2014-2019)

    5 North America Granisetron Revenue by Countries

    • 5.1 North America Granisetron Revenue by Countries (2014-2019)
    • 5.2 USA Granisetron Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Granisetron Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Granisetron Revenue and Growth Rate (2014-2019)

    6 Europe Granisetron Revenue by Countries

    • 6.1 Europe Granisetron Revenue by Countries (2014-2019)
    • 6.2 Germany Granisetron Revenue and Growth Rate (2014-2019)
    • 6.3 UK Granisetron Revenue and Growth Rate (2014-2019)
    • 6.4 France Granisetron Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Granisetron Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Granisetron Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Granisetron Revenue by Countries

    • 7.1 Asia-Pacific Granisetron Revenue by Countries (2014-2019)
    • 7.2 China Granisetron Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Granisetron Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Granisetron Revenue and Growth Rate (2014-2019)
    • 7.5 India Granisetron Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Granisetron Revenue and Growth Rate (2014-2019)

    8 South America Granisetron Revenue by Countries

    • 8.1 South America Granisetron Revenue by Countries (2014-2019)
    • 8.2 Brazil Granisetron Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Granisetron Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Granisetron Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Granisetron by Countries

    • 9.1 Middle East and Africa Granisetron Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Granisetron Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Granisetron Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Granisetron Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Granisetron Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Granisetron Revenue and Growth Rate (2014-2019)

    10 Global Granisetron Market Segment by Type

    • 10.1 Global Granisetron Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Granisetron Market Forecast by Type (2019-2024)
    • 10.3 Transdermal system Revenue Growth Rate (2014-2024)
    • 10.4 Injection Revenue Growth Rate (2014-2024)
    • 10.5 Oral Revenue Growth Rate (2014-2024)

    11 Global Granisetron Market Segment by Application

    • 11.1 Global Granisetron Revenue Market Share by Application (2014-2019)
    • 11.2 Granisetron Market Forecast by Application (2019-2024)
    • 11.3 Chemotherapy Revenue Growth (2014-2019)
    • 11.4 Post operative Revenue Growth (2014-2019)

    12 Global Granisetron Market Size Forecast (2019-2024)

    • 12.1 Global Granisetron Market Size Forecast (2019-2024)
    • 12.2 Global Granisetron Market Forecast by Regions (2019-2024)
    • 12.3 North America Granisetron Revenue Market Forecast (2019-2024)
    • 12.4 Europe Granisetron Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Granisetron Revenue Market Forecast (2019-2024)
    • 12.6 South America Granisetron Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Granisetron Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Granisetron. Industry analysis & Market Report on Granisetron is a syndicated market report, published as Global Granisetron Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Granisetron market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,690.04
      4,035.06
      5,380.08
      3,239.88
      4,859.82
      6,479.76
      531,361.20
      797,041.80
      1,062,722.40
      293,712.00
      440,568.00
      587,424.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report